A pragmatic approach to the design of population pharmacokinetic studies
Authors:
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 7 (2) , E408-E420
Abstract
The publication of a seminal article on nonlinear mixed-effect modeling led to a revolution in pharmacokinetics (PKs) with the introduction of the population approach. Since then, interest in obtaining accurate and precise estimates of population PK parameters has led to work on population PK study design that extended previous work on optimal sampling designs for individual PK parameter estimation. The issues and developments in the design of population PK studies are reviewed as a prelude to investigating, via simulation, the performance of 2 approaches (population Fisher information matrix D-optimal design and informative block [profile] randomized [IBR] design) for designing population PK studies. The results of our simulation study indicate that the designs based on the 2 approaches yielded efficient parameter estimates. The designs based on the 2 approaches performed similarly, and in some cases designs based on the IBR approach were slightly better. The ease with which the IBR designs can be generated makes them preferable in drug development, where pragmatism and time are of great consideration. We, therefore, refer to the IBR designs as pragmatic designs. Pragmatic designs that achieve high efficiency in the estimation parameters should be used in the design of population PK studies, and simulation should be used to determine the efficiency of the designs.Keywords
This publication has 24 references indexed in Scilit:
- Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population PharmacokineticsJournal of Biopharmaceutical Statistics, 2003
- Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokineticsStatistics in Medicine, 2002
- Optimal design in random-effects regression modelsBiometrika, 1997
- A computationally efficient approach for the design of population pharmacokinetic studiesJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Experimental design and efficient parameter estimation in population pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experimentsMathematical Biosciences, 1990
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Optimal nonuniform sampling interval and test-input design for identification of physiological systems from very limited dataIEEE Transactions on Automatic Control, 1979
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977